217 related articles for article (PubMed ID: 25856433)
1. Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway.
Pan J; Li H; Zhang B; Xiong R; Zhang Y; Kang WY; Chen W; Zhao ZB; Chen SD
PLoS One; 2015; 10(4):e0119204. PubMed ID: 25856433
[TBL] [Abstract][Full Text] [Related]
2. CIB1 protects against MPTP-induced neurotoxicity through inhibiting ASK1.
Yoon KW; Yang HS; Kim YM; Kim Y; Kang S; Sun W; Naik UP; Parise LV; Choi EJ
Sci Rep; 2017 Sep; 7(1):12178. PubMed ID: 28939911
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease.
Pan J; Xiao Q; Sheng CY; Hong Z; Yang HQ; Wang G; Ding JQ; Chen SD
Neurochem Int; 2009 Jun; 54(7):418-25. PubMed ID: 19428783
[TBL] [Abstract][Full Text] [Related]
4. Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3.
Miller WE; McDonald PH; Cai SF; Field ME; Davis RJ; Lefkowitz RJ
J Biol Chem; 2001 Jul; 276(30):27770-7. PubMed ID: 11356842
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Dvl-1/β-arrestin2/JNK3 interaction disrupts Wnt5a-JNK3 signaling and protects hippocampal CA1 neurons during cerebral ischemia reperfusion.
Wei X; Gong J; Ma J; Zhang T; Li Y; Lan T; Guo P; Qi S
Neuropharmacology; 2018 Jun; 135():11-21. PubMed ID: 29510185
[TBL] [Abstract][Full Text] [Related]
6. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
[TBL] [Abstract][Full Text] [Related]
7. MPTP activates ASK1-p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model.
Ray A; Sehgal N; Karunakaran S; Rangarajan G; Ravindranath V
Free Radic Biol Med; 2015 Oct; 87():312-25. PubMed ID: 26164633
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled estrogen receptor is involved in the neuroprotective effect of IGF-1 against MPTP/MPP
Yuan LJ; Wang XW; Wang HT; Zhang M; Sun JW; Chen WF
J Steroid Biochem Mol Biol; 2019 Sep; 192():105384. PubMed ID: 31175966
[TBL] [Abstract][Full Text] [Related]
9. Nesfatin-1 protects dopaminergic neurons against MPP
Shen XL; Song N; Du XX; Li Y; Xie JX; Jiang H
Sci Rep; 2017 Jan; 7():40961. PubMed ID: 28106099
[TBL] [Abstract][Full Text] [Related]
10. Small peptide inhibitor of JNKs protects against MPTP-induced nigral dopaminergic injury via inhibiting the JNK-signaling pathway.
Pan J; Qian J; Zhang Y; Ma J; Wang G; Xiao Q; Chen S; Ding J
Lab Invest; 2010 Feb; 90(2):156-67. PubMed ID: 20010851
[TBL] [Abstract][Full Text] [Related]
11. The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus.
Guo C; Whitmarsh AJ
J Biol Chem; 2008 Jun; 283(23):15903-11. PubMed ID: 18408005
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation.
Lee KW; Zhao X; Im JY; Grosso H; Jang WH; Chan TW; Sonsalla PK; German DC; Ichijo H; Junn E; Mouradian MM
PLoS One; 2012; 7(1):e29935. PubMed ID: 22253830
[TBL] [Abstract][Full Text] [Related]
13. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
[TBL] [Abstract][Full Text] [Related]
14. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
Choi YJ; Kim DW; Shin MJ; Yeo HJ; Yeo EJ; Lee LR; Song Y; Kim DS; Han KH; Park J; Lee KW; Park JK; Eum WS; Choi SY
Molecules; 2021 Jun; 26(11):. PubMed ID: 34206041
[TBL] [Abstract][Full Text] [Related]
15. beta-Arrestins facilitate ubiquitin-dependent degradation of apoptosis signal-regulating kinase 1 (ASK1) and attenuate H2O2-induced apoptosis.
Zhang Z; Hao J; Zhao Z; Ben P; Fang F; Shi L; Gao Y; Liu J; Wen C; Luo L; Yin Z
Cell Signal; 2009 Jul; 21(7):1195-206. PubMed ID: 19306926
[TBL] [Abstract][Full Text] [Related]
16. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
Zhai A; Zhu X; Wang X; Chen R; Wang H
Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
[TBL] [Abstract][Full Text] [Related]
17. Silencing RNF13 Alleviates Parkinson's Disease - Like Problems in Mouse Models by Regulating the Endoplasmic Reticulum Stress-Mediated IRE1α-TRAF2-ASK1-JNK Pathway.
Ji M; Niu S; Guo J; Mi H; Jiang P
J Mol Neurosci; 2020 Dec; 70(12):1977-1986. PubMed ID: 32617872
[TBL] [Abstract][Full Text] [Related]
18. Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.
Seo J; Tsakem EL; Breitman M; Gurevich VV
J Biol Chem; 2011 Aug; 286(32):27894-901. PubMed ID: 21715332
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade.
Hu X; Weng Z; Chu CT; Zhang L; Cao G; Gao Y; Signore A; Zhu J; Hastings T; Greenamyre JT; Chen J
J Neurosci; 2011 Jan; 31(1):247-61. PubMed ID: 21209210
[TBL] [Abstract][Full Text] [Related]
20. Tristetraprolin destabilizes NOX2 mRNA and protects dopaminergic neurons from oxidative damage in Parkinson's disease.
Sun X; Zhang H; Xie L; Qian C; Ye Y; Mao H; Wang B; Zhang H; Zhang Y; He X; Zhang S
FASEB J; 2020 Nov; 34(11):15047-15061. PubMed ID: 32954540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
